Last reviewed · How we verify
Aminophylline group
At a glance
| Generic name | Aminophylline group |
|---|---|
| Also known as | Theophylline |
| Sponsor | Tanta University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Diuretic Effect of Aminophylline and Furosemide in Adult Patients Undergoing Cardiac Surgical Procedures (NA)
- Heart Rhythm Changes in Patients With Atrial Fibrillation After Cardiopulmonary Bypass: a Retrospective Analysis
- Intra-ureteric Aminophylline Instillation on Flexible Ureteroscopy Procedure (NA)
- Timing of Aminophylline and Recovery in Pediatric Ambulatory Surgery (PHASE3)
- Reversal of Complete Heart Block With Aminophylline in Inferior Wall Myocardial Infarction Patients (PHASE4)
- Inhaled Nitric Oxide for High Amplitude Pulmonary Edema (HAPE) (NA)
- Efficacy of Intra-Ureteric Aminophylline Installation After Failed Stone Accessibility by Semi-rigid Ureteroscopy. Prospective Trial (NA)
- Effects of Aminophylline Bolus on TCI (Target Controlled Infusion) Concentrations at Return of Responsiveness
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Aminophylline group CI brief — competitive landscape report
- Aminophylline group updates RSS · CI watch RSS
- Tanta University portfolio CI